Pain Management · Brandon, FL
NPI
1467553966
Since 2006
Specialty
Pain Management
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
403 S Kings Ave Ste 201
Brandon, FL, 33511
Phone (813) 872-4492
Groups this clinician bills Medicare through
Medicare paid, 2024
$195K
2,426 services
Medicare patients, 2024
353
Average age 69
Drug cost, 2024
$548K
12,890 prescriptions
Company payments, 2025
$920
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bruce A Piszel was code 99214 (office e&m - established), 1,276 times for 327 patients. In total Bruce A Piszel billed 2,426 services in 41 codes, and Medicare paid $195K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,276 | 327 | $89.28 | $114K |
| 99213 Office E&M - Established | Office | 366 | 194 | $54.45 | $20K |
| 80307 Drug Tests | Office | 95 | 91 | $59.62 | $5,664 |
| 64494 Nerve Block Injection - Back | Facility | 69 | 46 | $56.88 | $3,924 |
| 64493 Nerve Block Injection - Back | Facility | 68 | 44 | $99.67 | $6,778 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 62 | 27 | $0.39 | $23.92 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 56 | 21 | $0.78 | $43.67 |
| 64490 Nerve Block Injection - Back | Facility | 43 | 24 | $96.54 | $4,151 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 42 | 39 | $204.04 | $8,570 |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 42 | 39 | $64.40 | $2,705 |
| 64491 Nerve Block Injection - Back | Facility | 41 | 23 | $53.93 | $2,211 |
| 99204 Office E&M - New | Office | 30 | 30 | $103.66 | $3,110 |
| 64483 Nerve Block Injection - Back | Facility | 30 | 25 | $109.33 | $3,280 |
| 62321 Nerve Block Injection - Back | Facility | 22 | 19 | $75.49 | $1,661 |
| 64633 Destruction by Neurolytic Agent - Back | Facility | 21 | 18 | $164.32 | $3,451 |
By year: 2022 $295K for 3,916 services; 2023 $234K for 3,125 services; 2024 $195K for 2,426 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 95 | 91 | $59.62 | $5,664 |
Medicare prescription drug claims, 2024
In 2024, the drug Bruce A Piszel prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 3,152 prescriptions and refills. In total Bruce A Piszel wrote 12,890 Medicare prescriptions that cost $548K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 3,152 | 3,153 | 388 | $127K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,394 | 2,396 | 339 | $73K |
| Oxycodone Hcl Generic | 1,824 | 1,824 | 224 | $42K |
| Morphine Sulfate Er Morphine Sulfate | 949 | 949 | 104 | $22K |
| Pregabalin Generic | 817 | 860 | 129 | $17K |
| Tramadol Hcl Generic | 539 | 541 | 102 | $6,440 |
| Gabapentin Generic | 319 | 358 | 100 | $4,118 |
| Hydromorphone Hcl Generic | 294 | 294 | 41 | $7,442 |
| Morphine Sulfate Generic | 268 | 268 | 31 | $8,773 |
| Carisoprodol Generic | 243 | 249 | 26 | $3,080 |
| Zolpidem Tartrate Generic | 161 | 163 | 25 | $821 |
| Cyclobenzaprine Hcl Generic | 158 | 173 | 58 | $1,805 |
| Fentanyl Generic | 142 | 142 | 14 | $18K |
| Tizanidine Hcl Generic | 126 | 139 | 49 | $1,338 |
| Oxycontin Oxycodone Hcl | 111 | 111 | 12 | $85K |
Brand drugs: 514 claims; generic drugs: 12,376 claims; opioid claims: 10,044.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bruce A Piszel $920 ($920 in general payments such as food, travel and fees) from 9 companies. The largest payer was Boston Scientific Corporation with $511.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.